The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis
Open accessAbstract
BACKGROUND: Older patients with severe aortic stenosis (AS) are increasingly identified as having cardiac amyloidosis (CA). It is unknown whether concomitant AS-CA has worse outcomes or results in futility of transcatheter aortic valve replacement (TAVR). OBJECTIVES: This study identified clinical characteristics and outcomes of AS-CA compared with lone AS. METHODS: technetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) bone scintigraphy (Perugini grade 0: negative; grades 1 to 3: increasingly positive) before intervention. Transthyretin-CA (ATTR) was diagnosed by DPD and absence of a clonal immunoglobulin, and light-chain CA (AL) was diagnosed via tissue biopsy. National registries captured all-cause mortality. RESULTS: A total of 407 patients (age 83.4 ± 6.5 years; 49.8% men) were recruited. DPD was positive in 48 patients (11.8%; grade 1: 3.9% [n = 16]; grade 2/3: 7.9% [n = 32]). AL was diagnosed in 1 patient with grade 1. Patients with grade 2/3 had worse functional capacity, biomarkers (N-terminal pro-brain natriuretic peptide and/or high-sensitivity troponin T), and biventricular remodeling. A clinical score (RAISE) that used left ventricular remodeling (hypertrophy/diastolic dysfunction), age, injury (high-sensitivity troponin T), systemic involvement, and electrical abnormalities (right bundle branch block/low voltages) was developed to predict the presence of AS-CA (area under the curve: 0.86; 95% confidence interval: 0.78 to 0.94; p < 0.001). Decisions by the heart team (DPD-blinded) resulted in TAVR (333 [81.6%]), surgical AVR (10 [2.5%]), or medical management (65 [15.9%]). After a median of 1.7 years, 23% of patients died. One-year mortality was worse in all patients with AS-CA (grade: 1 to 3) than those with lone AS (24.5% vs. 13.9%; p = 0.05). TAVR improved survival versus medical management; AS-CA survival post-TAVR did not differ from lone AS (p = 0.36). CONCLUSIONS: Concomitant pathology of AS-CA is common in older patients with AS and can be predicted clinically. AS-CA has worse clinical presentation and a trend toward worse prognosis, unless treated. Therefore, TAVR should not be withheld in AS-CA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lang, R. M., Badano, L. P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., Flachskampf, F. A., Foster, E., Goldstein, S. A., Kuznetsova, T., et al. (2015) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.10.003 · Cited by 12,362
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176857 · Cited by 8,495
Lang, R. M., Badano, L. P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., Flachskampf, F. A., Foster, E., Goldstein, S. A., Kuznetsova, T., et al. (2015) · European Heart Journal – Cardiovascular Imaging · doi:10.1093/ehjci/jev014 · Cited by 8,361
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Rodriguez Muñoz, D., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx391 · Cited by 6,243
Self-citationEchocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I., & Reichek, N. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90771-x · Cited by 6,229
Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., Dokainish, H., Edvardsen, T., Flachskampf, F. A., Gillebert, T. C., Klein, A. L., Lancellotti, P., et al. (2016) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2016.01.011 · Cited by 5,262
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,339
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C.-C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716153 · Cited by 3,047
Self-citationNonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Gillmore, J. D., Maurer, M. S., Falk, R. H., Merlini, G., Damy, T., Dispenzieri, A., Wechalekar, A. D., Berk, J. L., Quarta, C. C., Grogan, M., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.021612 · Cited by 2,081
Self-citationAHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram
Surawicz, B., Childers, R., Deal, B. J., & Gettes, L. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.013 · Cited by 2,032
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
Benson, M. D., Waddington-Cruz, M., Berk, J. L., Polydefkis, M., Dyck, P. J., Wang, A. K., Planté-Bordeneuve, V., Barroso, F. A., Merlini, G., Obici, L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716793 · Cited by 1,452
Baumgartner, H., Hung, J., Bermejo, J., Chambers, J. B., Edvardsen, T., Goldstein, S., Lancellotti, P., LeFevre, M., Miller, F., & Otto, C. M. (2017) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2017.02.009 · Cited by 1,349
Perugini, E., Guidalotti, P. L., Salvi, F., Cooke, R. M. T., Pettinato, C., Riva, L., Leone, O., Farsad, M., Ciliberti, P., Bacchi-Reggiani, L., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.073 · Cited by 981
Kapadia, S. R., Leon, M. B., Makkar, R. R., Tuzcu, E. M., Svensson, L. G., Kodali, S., Webb, J. G., Mack, M. J., Douglas, P. S., Thourani, V. H., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60290-2 · Cited by 867
Recommendations for the Standardization and Interpretation of the Electrocardiogram
Kligfield, P., Gettes, L. S., Bailey, J. J., Childers, R., Deal, B. J., Hancock, E. W., van Herpen, G., Kors, J. A., Macfarlane, P., Mirvis, D. M., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.024 · Cited by 807
Castaño, A., Narotsky, D. L., Hamid, N., Khalique, O. K., Morgenstern, R., DeLuca, A., Rubin, J., Chiuzan, C., Nazif, T., Vahl, T., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx350 · Cited by 726
2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Muñoz, D. R., et al. (2018) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2017.12.013 · Cited by 672
The effect of aortic valve replacement on survival.
Schwarz, F., Baumann, P., Manthey, J., Hoffmann, M., Schuler, G., Mehmel, H. C., Schmitz, W., & Kübler, W. (1982) · Circulation · doi:10.1161/01.cir.66.5.1105 · Cited by 584
Maurer, M. S., Bokhari, S., Damy, T., Dorbala, S., Drachman, B. M., Fontana, M., Grogan, M., Kristen, A. V., Lousada, I., Nativi-Nicolau, J., et al. (2019) · Circulation: Heart Failure · doi:10.1161/circheartfailure.119.006075 · Cited by 568
Self-citationTreibel, T. A., Fontana, M., Gilbertson, J. A., Castelletti, S., White, S. K., Scully, P. R., Roberts, N., Hutt, D. F., Rowczenio, D. M., Whelan, C. J., et al. (2016) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.116.005066 · Cited by 317
Self-citationAortic Stenosis and Cardiac Amyloidosis
Ternacle, J., Krapf, L., Mohty, D., Magne, J., Nguyen, A., Galat, A., Gallet, R., Teiger, E., Côté, N., Clavel, M.-A., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.09.056 · Cited by 294
Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy
Judge, D. P., Heitner, S. B., Falk, R. H., Maurer, M. S., Shah, S. J., Witteles, R. M., Grogan, M., Selby, V. N., Jacoby, D., Hanna, M., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.012 · Cited by 263
The Prevalence, Incidence, Progression, and Risks of Aortic Valve Sclerosis
Coffey, S., Cox, B., & Williams, M. J. A. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.018 · Cited by 255
Hutt, D. F., Quigley, A.-M., Page, J., Hall, M. L., Burniston, M., Gopaul, D., Lane, T., Whelan, C. J., Lachmann, H. J., Gillmore, J. D., et al. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu107 · Cited by 250
Self-citationImmunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment
Gertz, M. A. (2014) · American Journal of Hematology · doi:10.1002/ajh.23828 · Cited by 245
Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis
Cavalcante, J. L., Rijal, S., Abdelkarim, I., Althouse, A. D., Sharbaugh, M. S., Fridman, Y., Soman, P., Forman, D. E., Schindler, J. T., Gleason, T. G., et al. (2016) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-017-0415-x · Cited by 220
Scully, P. R., Patel, K. P., Treibel, T. A., Thornton, G. D., Hughes, R. K., Chadalavada, S., Katsoulis, M., Hartman, N., Fontana, M., Pugliese, F., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa170 · Cited by 202
Self-citationPathophysiology and treatment of cardiac amyloidosis
Gertz, M. A., Dispenzieri, A., & Sher, T. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.165 · Cited by 170
A novel mechano‐enzymatic cleavage mechanism underlies transthyretin amyloidogenesis
Marcoux, J., Mangione, P. P., Porcari, R., Degiacomi, M. T., Verona, G., Taylor, G. W., Giorgetti, S., Raimondi, S., Sanglier‐Cianférani, S., Benesch, J. L., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201505357 · Cited by 166
Self-citationPrevalence of Cardiac Amyloidosis in Patients Referred for Transcatheter Aortic Valve Replacement
Scully, P. R., Treibel, T. A., Fontana, M., Lloyd, G., Mullen, M. J., Pugliese, F., Hartman, N., Hawkins, P. N., Menezes, L., & Moon, J. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.037 · Cited by 156
Self-citationAortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?
Galat, A., Guellich, A., Bodez, D., Slama, M., Dijos, M., Messika–Zeitoun, D., Milleron, O., Attias, D., Dubois‐Randé, J., Mohty, D., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw033 · Cited by 151
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Baumgartner, H., Falk, V., Bax, J. J., Bonis, M. D., Hamm, C. W., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Muñoz, D. R., et al. (2018) · Kardiologia Polska · doi:10.5603/kp.2018.0013 · Cited by 149
Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment
Gertz, M. A. (2018) · American journal of hematology/oncology · doi:10.1002/ajh.25149 · Cited by 130
Identification of TTR-Related Subclinical Amyloidosis With 99mTc-DPD Scintigraphy
Longhi, S., Guidalotti, P., Quarta, C. C., Gagliardi, C., Milandri, A., Lorenzini, M., Potena, L., Leone, O., Bartolomei, I., Pastorelli, F., et al. (2014) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2014.03.004 · Cited by 129
Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis
Rosenblum, H., Masri, A., Narotsky, D. L., Goldsmith, J., Hamid, N. B., Hahn, R. T., Kodali, S., Vahl, T. P., Nazif, T. M., Khalique, O. K., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1974 · Cited by 123
Nitsche, C., Aschauer, S., Kammerlander, A., Schneider, M., Poschner, T., Duca, F., Binder, C., Koschutnik, M., Stiftinger, J., Goliasch, G., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1756 · Cited by 120
Self-citationIdentifying Cardiac Amyloid in Aortic Stenosis
Scully, P., Patel, K. P., Saberwal, B., Klotz, E., Augusto, J., Thornton, G., Hughes, R., Manisty, C., Lloyd, G., Newton, J., et al. (2020) · JACC Cardiovascular Imaging · doi:10.1016/j.jcmg.2020.05.029 · Cited by 110
Self-citationKing, D. L., Coffin, L. E.-K., & Maurer, M. S. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01944-7 · Cited by 91
Progression rate of severity of aortic stenosis in patients with rheumatoid arthritis
Bois, J. P., Crowson, C. S., Khullar, T., Achenbach, S. J., Krause, M. L., & Mankad, R. (2017) · Echocardiography · doi:10.1111/echo.13652 · Cited by 16
Cited by
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab395 · Cited by 5,685
2025 ESC/EACTS Guidelines for the management of valvular heart disease
Praz, F., Borger, M. A., Lanz, J., Marin-Cuartas, M., Abreu, A., Adamo, M., Ajmone Marsan, N., Barili, F., Bonaros, N., Cosyns, B., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf194 · Cited by 1,072
Kittleson, M. M., Ruberg, F. L., Ambardekar, A. V., Brannagan, T. H., Cheng, R. K., Clarke, J. O., Dember, L. M., Frantz, J. G., Hershberger, R. E., Maurer, M. S., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.022 · Cited by 640
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Beyersdorf, F., Vahanian, A., Milojevic, M., Praz, F., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2021) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezab389 · Cited by 622
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2022.05.006 · Cited by 527
Metadata
- Authors
- Nitsche, C., Scully, P. R., Patel, K. P., Kammerlander, A. A., Koschutnik, M., Dona, C., Wollenweber, T., Ahmed, N., Thornton, G. D., Kelion, A. D., Sabharwal, N., Newton, J. D., Ozkor, M., Kennon, S., Mullen, M., Lloyd, G., Fontana, M., Hawkins, P. N., Pugliese, F., Menezes, L. J., Moon, J. C., Mascherbauer, J., & Treibel, T. A.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 77
- Issue
- 2
- Pages
- 128-139
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W3103154679
- Cited by
- 377
- References
- 39
- FWCI
- 12.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.